Financial results - SALIX PHARM SRL

Financial Summary - Salix Pharm Srl
Unique identification code: 10354331
Registration number: J1998000132265
Nace: 4773
Sales - Ron
-
Net Profit - Ron
-3.889
Employees
Open Account
Company Salix Pharm Srl with Fiscal Code 10354331 recorded a turnover of 2024 of - , with a net profit of -3.889 and having an average number of employees of - . The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Salix Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 250.225 231.925 135.165 65.883 71.606 48.185 0 0 0 0
Total Income - EUR 250.268 232.060 158.397 65.884 71.607 214.050 1.565 34 0 105
Total Expenses - EUR 254.378 228.374 166.352 100.500 102.935 82.793 4.661 4.495 4.676 3.994
Gross Profit/Loss - EUR -4.110 3.686 -7.954 -34.616 -31.328 131.258 -3.096 -4.461 -4.676 -3.889
Net Profit/Loss - EUR -4.562 2.712 -9.498 -35.278 -32.046 129.071 -3.096 -4.461 -4.676 -3.889
Employees 7 5 4 4 3 3 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Salix Pharm Srl

Rating financiar

Financial Rating -
SALIX PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Salix Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Salix Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Salix Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Salix Pharm Srl - CUI 10354331

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 46.870 43.613 36.155 29.329 28.868 26.957 24.014 22.750 21.347 19.901
Current Assets 75.586 53.150 39.114 32.220 27.675 102.073 2.673 1.214 1.700 1.749
Inventories 44.630 33.717 19.920 19.698 17.436 0 0 0 0 0
Receivables 23.690 11.055 4.222 9.284 7.189 242 821 914 1.339 1.486
Cash 7.265 8.377 14.971 3.237 3.051 101.831 1.852 300 361 263
Shareholders Funds 48.738 40.053 28.078 -7.716 -39.612 90.209 26.694 22.316 17.572 13.585
Social Capital 45 45 88 86 84 83 81 81 81 80
Debts 74.058 57.324 47.716 69.536 96.720 38.820 0 1.649 5.475 8.066
Income in Advance 300 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.749 euro in 2024 which includes Inventories of 0 euro, Receivables of 1.486 euro and cash availability of 263 euro.
The company's Equity was valued at 13.585 euro, while total Liabilities amounted to 8.066 euro. Equity decreased by -3.889 euro, from 17.572 euro in 2023, to 13.585 in 2024.

Risk Reports Prices

Reviews - Salix Pharm Srl

Comments - Salix Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.